MRF-Logo2019-Horizontal-RGB
Re: SIRT
REGISTER
The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. Content within the patient forum is user-generated and has not been reviewed by medical professionals. Other sections of the Melanoma Research Foundation website include information that has been reviewed by medical professionals as appropriate. All medical decisions should be made in consultation with your doctor or other qualified medical professional.

Re: SIRT

› Forums › Ocular Melanoma Community › SIRT › Re: SIRT

    • August 7, 2010 at 11:08 pm
    sselig
    Participant

      Hello,

      My husband had sir-spheres to his liver for ocular melanoma mets almost 3 years ago (at the age of 35) and, combined with radio-frequency ablation to the residual tumor about a year later, his liver has been free of tumor since then.

      If you haven't done so already, please look at the Ocular Melanoma Foundation (OMF) webpage: http://www.ocularmelanoma.org and our patient forum on the site in case this would be helpful to you.  At this time (8/2010) we have about 1000 members on the patient forum and it is growing every day.

      I hope the sirsphers treatment is as successful for your husband has it has been for mine.

      Best,

      Sara

    About the MRF Patient Forum

    The MRF Patient Forum is the oldest and largest online community of people affected by melanoma. It is designed to provide peer support and information to caregivers, patients, family and friends. There is no better place to discuss different parts of your journey with this cancer and find the friends and support resources to make that journey more bearable.

    The information on the forum is open and accessible to everyone. To add a new topic or to post a reply, you must be a registered user. Please note that you will be able to post both topics and replies anonymously even though you are logged in. All posts must abide by MRF posting policies.

    Popular Topics